Brief: Heidelberg Pharma 9-month Sales Up 2 Pct To EUR 1.7 Billion
Feb 7 (Reuters) - Heidelberg Pharma AG WL6G.DE :
* NINE-MONTH SALES OF EUR1,693 MILLION APPROXIMATELY 2
PERCENT UP
ON PREVIOUS YEAR
* TARGETS FOR FINANCIAL YEAR 2018/2019 AS A WHOLE STILL IN
SIGHT
* AT EUR101 MILLION,9MTH EBITDA EXCLUDING RESTRUCTURING
RESULT
DID NOT QUITE REACH PREVIOUS YEAR'S FIGURE OF EUR105
* 9MTH EBIT EXCLUDING RESTRUCTURING RESULT TOTALED EUR49
MILLION
(PREVIOUS YEAR: EUR54 MILLION)
Further company coverage: WL6G.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Heidelberg Pharma AG
See all newsBrief: Heidelberg Pharma And Huadong Medicine Receive Nmpa Approval For Hdp-101 Trial In China
Germany's Heidelberg Pharma H1 sales revenue surges, driven by milestone payments
Brief: Heidelberg Pharma Says Co. And Healthcare Royalty Announce Amendment To Existing Royalty Agreement
Brief: Redhill Biopharma Secures Allowance Of Key Chinese Patent Application For Proprietary COVID-19 Treatment, RHB-107
Brief: Heidelberg Pharma Amends Royalty Financing With Healthcare Royalty